These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oseltamivir-resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient. Shetty AK, Ross GA, Pranikoff T, Gubareva LV, Sechrist C, Guirand DM, Abramson J, Lin JJ. Pediatr Transplant; 2012 Aug; 16(5):E153-7. PubMed ID: 22764830 [Abstract] [Full Text] [Related]
5. Post-exposure prophylaxis for H1N1 with oseltamivir in renal allograft recipient--safe and effective without any immunosuppresive drug interaction. Kute V, Goplani KR, Godara SM, Shah PR, Vanikar AV, Trivedii HL. J Assoc Physicians India; 2011 Jan; 59():49-51. PubMed ID: 21751666 [Abstract] [Full Text] [Related]
6. The use of antiviral agents for the management of severe influenza. Smith JR, Ariano RE, Toovey S. Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416 [Abstract] [Full Text] [Related]
7. High mortality in critically ill patients infected with 2009 pandemic influenza A (H1N1) with pneumonia and acute kidney injury. Kute VB, Godara SM, Goplani KR, Gumber MR, Shah PR, Vanikar AV, Shah VR, Trivedi HL. Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):83-9. PubMed ID: 21196619 [Abstract] [Full Text] [Related]
8. Outcome of influenza infection managed with oseltamivir in lung transplant recipients. Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC. J Heart Lung Transplant; 2008 Mar; 27(3):282-8. PubMed ID: 18342750 [Abstract] [Full Text] [Related]
9. H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy might be life saving. Suyani E, Aki Z, Güzel Ö, Altindal S, Senol E, Sucak G. Transpl Infect Dis; 2011 Apr; 13(2):208-12. PubMed ID: 21214698 [Abstract] [Full Text] [Related]
13. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons. Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S. Clin Infect Dis; 2009 Dec 15; 49(12):1828-35. PubMed ID: 19911968 [Abstract] [Full Text] [Related]
14. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection. Esposito S, Molteni CG, Colombo C, Daleno C, Daccò V, Lackenby A, Principi N. J Clin Virol; 2010 May 15; 48(1):62-5. PubMed ID: 20335065 [Abstract] [Full Text] [Related]
15. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients. Ison MG, Szakaly P, Shapira MY, Kriván G, Nist A, Dutkowski R. Antivir Ther; 2012 May 15; 17(6):955-64. PubMed ID: 22728756 [Abstract] [Full Text] [Related]
16. Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus. Medeiros R, Rameix-Welti MA, Lorin V, Ribaud P, Manuguerra JC, Socie G, Scieux C, Naffakh N, van der Werf S. Antivir Ther; 2007 May 15; 12(4):571-6. PubMed ID: 17668567 [Abstract] [Full Text] [Related]